Growth potential OpiAID is a data science focused wellness company with a legitimate need to scale its decision support technology for clinicians in MAT programs, suggesting opportunities to upsell enhanced analytics, integration, or platform add-ons as they expand.

SBIR and grants Past and ongoing government funding (SBIR grants from NIH/NIDA and federal grants) indicate a favorable funding environment and potential for co-development, pilot programs, or grant-aligned solutions that could be packaged for future customers.

Clinical impact Focus on improving patient retention and outcomes in opioid use disorder positions opportunities to offer outcomes analytics, reporting dashboards, and payer-focused value propositions around cost savings and reduced readmissions.

Market positioning Recognized as an AI and data analytics leader in the state and demonstrated startup traction suggests credibility to approach mid-sized clinics and specialty addiction treatment networks seeking proven technology partners.

Strategic partnerships Existing tech stack and multi-channel presence (WordPress, Shopify, data tools) implies potential for partnerships with EHR/clinic management firms, telehealth platforms, or revenue cycle leaders to embed or bundle OpiAID capabilities.